InvestSMART

Neuren Pharmaceuticals Limited (ASX: NEU) - Announcements

Current share price for NEU : $20.430 0.15 (0.74%)+

ASX company news and announcements for Neuren Pharmaceuticals Limited (NEU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neuren Pharmaceuticals Limited (NEU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neuren Pharmaceuticals Limited (NEU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neuren Pharmaceuticals Limited (NEU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,590 Update - Notification of buy-back - NEU 31 Mar 2025 9:06AM $12.260 $20.430 risen by 66.64%
$2,590 Update - Notification of buy-back - NEU 28 Mar 2025 8:55AM $12.010 $20.430 risen by 70.11%
$2,590 Neuren initiates development of NNZ-2591 to treat HIE 27 Mar 2025 9:36AM $11.930 $20.430 risen by 71.25%
$2,590 Update - Notification of buy-back - NEU 27 Mar 2025 8:55AM $11.930 $20.430 risen by 71.25%
$2,590 Update - Notification of buy-back - NEU 26 Mar 2025 8:30AM $12.620 $20.430 risen by 61.89%
$2,590 Update - Notification of buy-back - NEU 25 Mar 2025 8:18AM $12.470 $20.430 risen by 63.83%
$2,590 Update - Notification of buy-back - NEU 24 Mar 2025 8:47AM $12.550 $20.430 risen by 62.79%
$2,590 Update - Notification of buy-back - NEU 21 Mar 2025 7:30AM $12.600 $20.430 risen by 62.14%
$2,590 Update - Notification of buy-back - NEU 20 Mar 2025 8:53AM $12.260 $20.430 risen by 66.64%
$2,590 Update - Notification of buy-back - NEU 19 Mar 2025 9:11AM $12.300 $20.430 risen by 66.10%
$2,590 Update - Notification of buy-back - NEU 18 Mar 2025 9:07AM $12.060 $20.430 risen by 69.40%
$2,590 Update - Notification of buy-back - NEU 17 Mar 2025 9:02AM $11.680 $20.430 risen by 74.91%
$2,590 Update - Notification of buy-back - NEU 14 Mar 2025 8:42AM $11.030 $20.430 risen by 85.22%
$2,590 Update - Notification of buy-back - NEU 13 Mar 2025 8:57AM $11.100 $20.430 risen by 84.05%
$2,590 Update - Notification of buy-back - NEU 12 Mar 2025 8:39AM $11.400 $20.430 risen by 79.21%
$2,590 Becoming a substantial holder 12 Mar 2025 7:30AM $11.400 $20.430 risen by 79.21%
$2,590 Application for quotation of securities - NEU 11 Mar 2025 3:14PM $11.350 $20.430 risen by 80%
$2,590 Update - Notification of buy-back - NEU 11 Mar 2025 8:53AM $12.130 $20.430 risen by 68.43%
$2,590 Update - Notification of buy-back - NEU 10 Mar 2025 7:58AM $12.280 $20.430 risen by 66.37%
$2,590 Notification of cessation of securities - NEU 7 Mar 2025 8:50AM $12.590 $20.430 risen by 62.27%
$2,590 Update - Notification of buy-back - NEU 7 Mar 2025 8:20AM $12.590 $20.430 risen by 62.27%
$2,590 Update - Notification of buy-back - NEU 6 Mar 2025 8:39AM $12.430 $20.430 risen by 64.36%
$2,590 Ceasing to be a substantial holder 6 Mar 2025 7:30AM $12.430 $20.430 risen by 64.36%
$2,590 Update - Notification of buy-back - NEU 5 Mar 2025 7:46AM $12.330 $20.430 risen by 65.69%
$2,590 Update - Notification of buy-back - NEU 4 Mar 2025 7:30AM $13.210 $20.430 risen by 54.66%

151 - 175 of 833 results

Page 7 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.